Page last updated: 2024-08-16

salmeterol xinafoate and Nasal Catarrh

salmeterol xinafoate has been researched along with Nasal Catarrh in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Babineau, DC; Bacharier, LB; Busse, WW; Cohen, RT; Gergen, PJ; Gern, JE; Gruchalla, RS; Hu, JW; Kercsmar, CM; Khurana Hershey, GK; Kim, H; Lamm, CI; Liu, AH; Makhija, MM; Pillai, D; Sigelman, SM; Togias, A; Wang, E; Wood, RA1
Chipps, B1

Other Studies

2 other study(ies) available for salmeterol xinafoate and Nasal Catarrh

ArticleYear
Rhinitis in children and adolescents with asthma: Ubiquitous, difficult to control, and associated with asthma outcomes.
    The Journal of allergy and clinical immunology, 2019, Volume: 143, Issue:3

    Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Anti-Allergic Agents; Asthma; Bronchodilator Agents; Child; Female; Fluticasone; Humans; Male; Phenotype; Prevalence; Rhinitis; Salmeterol Xinafoate; Severity of Illness Index

2019
Systemic reaction to omalizumab.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2006, Volume: 97, Issue:2

    Topics: Acetates; Adrenal Cortex Hormones; Aged; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis; Asthma; Cyclopropanes; Depression; Drug Hypersensitivity; Drug Therapy, Combination; Epinephrine; Female; Humans; Hypersensitivity; Hypertension; Methylprednisolone; Omalizumab; Quinolines; Rhinitis; Salmeterol Xinafoate; Seizures; Sulfides; Syncope

2006